(Q37570939)

21 August 2017

1 reference

title

Nosocomial RSV infection control and outbreak management (English)

1 reference

21 August 2017

1

Louis Bont

1 reference

21 August 2017

publication date

1 June 2009

1 reference

Paediatric Respiratory Reviews

21 August 2017

published in

1 reference

21 August 2017

volume

10 Suppl 1

1 reference

21 August 2017

page(s)

16-17

1 reference

Nosocomial respiratory syncytial virus infections in a paediatric department

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2809%2970008-9

7 January 2021

Molecular epidemiological analysis of a nosocomial outbreak of respiratory syncytial virus associated pneumonia in a kangaroo mother care unit in South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2809%2970008-9

7 January 2021

RSV outbreak in a paediatric intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2809%2970008-9

7 January 2021

Nosocomial infection: a risk factor for a complicated course in children with respiratory syncytial virus infection--results from a prospective multicenter German surveillance study

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2809%2970008-9

7 January 2021

Nosocomial respiratory syncytial virus infection in Canadian pediatric hospitals: a Pediatric Investigators Collaborative Network on Infections in Canada Study

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2809%2970008-9

7 January 2021

Transmission of viral respiratory infections in the home

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2809%2970008-9

7 January 2021

Prospective controlled study of four infection-control procedures to prevent nosocomial infection with respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2809%2970008-9

7 January 2021

Nosocomial respiratory syncytial virus infections: the cost-effectiveness and cost-benefit of infection control

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2809%2970008-9

7 January 2021

Experience with the use of palivizumab together with infection control measures to prevent respiratory syncytial virus outbreaks in neonatal intensive care units

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2809%2970008-9

7 January 2021

10.1016/S1526-0542(09)70008-9

Identifiers

DOI

1 reference

21 August 2017

1 reference